TC BioPharm (Holdings) PLC (TCBP)

0.6239 -0.01 (-0.94%) USD  |  NASDAQ  |  Nov 22, 16:00
0.6199 0.00 (0.00%) After-Hours: 20:00
More

TC BioPharm Free Cash Flow to Equity (Quarterly)

Free Cash Flow to Equity (Quarterly) Chart

View Free Cash Flow to Equity (Quarterly) for TCBP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Free Cash Flow to Equity (Quarterly) Data

View and export this data back to 2021. Upgrade now.
Date Value
September 30, 2021 --

Free Cash Flow to Equity Definition

Free cash flow to equity measures the total free cash flow divided by shareholder's equity. This metric can be used as a gauge for cash flow available for shareholders.

Read full definition.

Free Cash Flow to Equity (Quarterly) Range, Past 5 Years

Upgrade
Minimum
Sep 2021
Upgrade
Maximum
Sep 2021
Upgrade
Average
Upgrade
Median
Sep 2021

Free Cash Flow to Equity (Quarterly) Benchmarks

Adaptimmune Therapeutics PLC Upgrade
Biodexa Pharmaceuticals PLC --
Verona Pharma PLC Upgrade
NuCana PLC --
Autolus Therapeutics PLC --

Free Cash Flow to Equity (Quarterly) Related Metrics

Cash from Operations (Quarterly) Upgrade
Cash from Investing (Quarterly) Upgrade
Cash from Financing (Quarterly) Upgrade
Free Cash Flow Upgrade
Free Cash Flow Per Share (Quarterly) Upgrade
Free Cash Flow Yield Upgrade